Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0E1XL
|
||||
| Former ID |
DAP000502
|
||||
| Drug Name |
Levetiracetam
|
||||
| Synonyms |
Keppra; Levetiractam; Leviteracetam; Torleva; Keppra XR; Levetiracetam [INN]; Ucb L060; Etiracetam levo-isomer; Keppra (TN); L-059; Levetiracetamum [INN-Latin]; SIB-S1; UCB-22059; UCB-L 059; UCB-L059; Etiracetam, S-isomer; Keppra, Keppra XR),Levetiracetam; (-)-(S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide; (2S)-2-(2-oxopyrrolidin-1-yl)butanamide; (S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Therapeutic Class |
Anticonvulsants
|
||||
| Company |
UCB Pharmaceuticals Inc
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C8H14N2O2
|
||||
| InChI |
InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1
|
||||
| InChIKey |
HPHUVLMMVZITSG-LURJTMIESA-N
|
||||
| CAS Number |
CAS 102767-28-2
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
10043, 7847774, 7979767, 11039358, 11528730, 12013706, 15321884, 15321885, 26719810, 39317891, 46386557, 48416166, 49681695, 49830155, 50363327, 56310923, 56312936, 56312991, 56313270, 57359126, 68530790, 90341134, 91614180, 92308297, 92308916, 92713787, 93166400, 99437106, 103397964, 113863233, 118048597, 118317474, 121361595, 124658926, 124757185, 124801236, 125163989, 125307963, 126629740, 126645371, 126655872, 128093760, 131293132, 134338679, 135017078, 135610154, 135684175, 135692116, 135697608, 136375572
|
||||
| SuperDrug ATC ID |
N03AX14
|
||||
| SuperDrug CAS ID |
cas=102767282
|
||||
| Target and Pathway | |||||
| Target(s) | Synaptic vesicle glycoprotein 2A | Target Info | Modulator | [556264] | |
| KEGG Pathway | ECM-receptor interaction | ||||
| References | |||||
| Ref 536756 | Use of second-generation antiepileptic drugs in the pediatric population. Paediatr Drugs. 2008;10(4):217-54. | ||||
| Ref 541908 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6826). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.